The latest price target for Bionano Genomics (NASDAQ:BNGO) was reported by Ladenburg Thalmann on November 15, 2024. The analyst firm set a price target for $0.00 expecting BNGO to fall to within 12 months (a possible -100.00% downside). 5 analyst firms have reported ratings in the last year.

The latest analyst rating for Bionano Genomics (NASDAQ:BNGO) was provided by Ladenburg Thalmann, and Bionano Genomics downgraded their neutral rating.

There is no last upgrade for Bionano Genomics

The last downgrade for Bionano Genomics Inc happened on November 15, 2024 when Ladenburg Thalmann changed their price target from N/A to N/A for Bionano Genomics Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bionano Genomics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bionano Genomics was filed on November 15, 2024 so you should expect the next rating to be made available sometime around November 15, 2025.

While ratings are subjective and will change, the latest Bionano Genomics (BNGO) rating was a downgraded with a price target of $0.00 to $0.00. The current price Bionano Genomics (BNGO) is trading at is $0.20, which is out of the analyst’s predicted range.